Cargando…
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?
Autores principales: | Teofili, Luciana, Valentini, Caterina Giovanna, Rossi, Elena, De Stefano, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326952/ https://www.ncbi.nlm.nih.gov/pubmed/30518810 http://dx.doi.org/10.1038/s41375-018-0304-9 |
Ejemplares similares
-
Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera
por: Barbui, Tiziano, et al.
Publicado: (2018) -
Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data
por: Ghirardi, Arianna, et al.
Publicado: (2018) -
The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis
por: van Bommel, Erik JM, et al.
Publicado: (2021) -
Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera
por: Lilienthal, Patrick, et al.
Publicado: (2020) -
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis
por: Rombout‐Sestrienkova, Eva, et al.
Publicado: (2020)